SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-08-022348
Filing Date
2008-05-01
Accepted
2008-05-01 08:28:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 19227
  Complete submission text file 0000000000-08-022348.txt   27875
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filed for) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1